Table 6. Summary of the correlations between EOLPRO scores and other established scales and clinical measures.
| Measure | Spearman’s correlation coefficient (95% CI) | Effect size | p-value1 |
| Convergent validity | |||
| AKPS (n = 137) | 0.41 (0.26, 0.54) | moderate | <0.01* |
| BPI (n = 137) | 0.10 (−0.08, 0.26) | very weak | 0.25 |
| Proximity to death (n = 28) | 0.30 (−0.09, 0.59) | moderate | 0.13 |
| Divergent validity | |||
| EORTC QLQ-C15-PAL Question 10 (n = 127) | 0.02 (−0.15, 0.19) | negligible | 0.85 |
1
correlations were considered significant when the probability of making a type I error was less than 0.8% to allow for multiple testing;
*
statistically significant result; AKPS = Australian-modified Karnofsky Performance Status; BPI = Brief Pain Inventory; CI = bootstrap BCa confidence intervals.